Suzhou Genhouse Bio Co., Ltd.
Clinical trials sponsored by Suzhou Genhouse Bio Co., Ltd., explained in plain language.
-
New drug combo aims to block Cancer's growth signals
Disease control Not yet recruitingThis study tests two experimental oral drugs, GH55 and GH21, taken together by people with advanced solid tumors that have a specific genetic change in the MAPK pathway. The trial has two phases: first, to find the safest dose (Phase 1), and then to see if the combination can shr…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Not yet recruitingThis Phase 2 study tests two oral drugs, GH21 and D-1553, in 120 adults with advanced solid tumors that have a specific mutation called KRASG12C. Participants have already tried other treatments without success. The goal is to see if the combination can shrink tumors and control …
Phase: PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC